• Trametinib (GSK1120212): Applied MEK-ERK Inhibition in Cance

  2026-06-15

  Trametinib (GSK1120212) stands out as a potent, ATP-noncompetitive MEK1/2 inhibitor for dissecting MAPK/ERK pathway signaling and driving innovation in oncology research workflows. Its exceptional sensitivity in B-RAF mutated cell lines, data-driven protocol versatility, and recent mechanistic insights into telomerase regulation position it as an indispensable tool for translational and stem cell studies.

• Synergistic CDK4/6 and BET Inhibition Suppresses EMT in PDAC

  2026-06-15

  Gu et al. reveal that combining CDK4/6 and BET inhibitors not only suppresses pancreatic tumor growth but also reverses epithelial-to-mesenchymal transition (EMT) by targeting the GSK3β-mediated Wnt/β-catenin pathway. This study provides new mechanistic insight and highlights the potential for integrated pathway modulation in pancreatic ductal adenocarcinoma (PDAC) research.

• Sodium Overload Impairs Mitochondrial Energy and Drives NECS

  2026-06-14

  This study uncovers the mechanism by which sodium influx, mediated through TRPM4 activation, disrupts mitochondrial energy metabolism to induce necrosis via the NECSO pathway. The findings elucidate the link between Na+ homeostasis, mitochondrial dysfunction, and regulated cell death, providing a new perspective for mitochondrial membrane potential assays in apoptosis and disease research.

• Glycosylation-Mediated Inactivation of Midecamycin in Resist

  2026-06-13

  This study demonstrates that glycosylation with various sugar moieties at the 2′-OH site effectively inactivates midecamycin, expanding the known mechanisms of macrolide resistance. The findings inform strategies for antibiotic development and resistance monitoring in microbiology research.

• Pioglitazone: PPARγ Agonist Workflows in Inflammation Resear

  2026-06-12

  Pioglitazone, a selective PPARγ agonist from APExBIO, enables precision modeling of metabolic and inflammatory pathways with validated protocols for IBD and neurodegeneration. This article translates bench findings into robust workflows, highlights troubleshooting strategies, and presents the latest advances in macrophage polarization studies.

• Site-Specific PEGylation of IL-11 for Attenuating Lung Fibro

  2026-06-12

  This study introduces a receptor-biased interleukin-11 (IL-11) variant, engineered via site-specific PEGylation to selectively block GP130 binding, as a novel strategy to mitigate bleomycin-induced pulmonary fibrosis in mice. The findings demonstrate that targeted PEGylation can preserve IL-11Rα interaction, inhibit profibrotic signaling, and prolong cytokine half-life, setting a foundation for cytokine pathway modulation in fibrotic disease models.

• Bsa I (RNase-free): Technical Guide for DNA Cleavage Workflo

  2026-06-11

  Bsa I (RNase-free) offers precise DNA cleavage for molecular biology research requiring strict RNA integrity, such as gene cloning and DNA recombinant technology. Its RNase-free formulation minimizes RNA degradation, making it suitable for sensitive nucleic acid workflows, but it is not intended for diagnostic or medical use. Researchers should use this enzyme only in research protocols where RNase-free conditions are essential.

• Bacitracin (B1670): Technical Use and Protocol Parameters

  2026-06-11

  Bacitracin is a peptide antibiotic for laboratory-based antibacterial research, designed to disrupt bacterial growth by interfering with cell wall and peptidoglycan synthesis. It is not suitable for diagnostic or clinical applications and requires careful protocol adherence for reproducible results.

• AZD2461: Novel PARP Inhibitor for Advanced Breast Cancer Res

  2026-06-10

  AZD2461 stands out as a potent, next-generation PARP inhibitor, enabling researchers to dissect DNA repair mechanisms and overcome resistance in advanced breast cancer models. This article delivers actionable workflows, troubleshooting guidance, and comparative insights to maximize the utility of AZD2461 in both in vitro and in vivo studies.

• CK2α–VP2 Interaction Drives CIAV Replication and Pathogenesi

  2026-06-10

  This study uncovers how chicken infectious anemia virus (CIAV) exploits host CK2α to promote viral replication via direct interaction with the viral VP2 protein. Targeting the VP2–CK2α interface is highlighted as a promising strategy for antiviral intervention, with implications for both mechanistic understanding and host-directed therapy development.

• Cefepime (BMY-28142) in CNS Infection Models: Protocols & In

  2026-06-09

  Cefepime (BMY-28142) stands out for its ability to cross the blood-brain barrier and its robust, broad-spectrum antimicrobial activity, making it a cornerstone for modeling central nervous system (CNS) infections. This guide integrates the latest comparative resistance data, actionable workflow enhancements, and troubleshooting strategies for advanced translational research.

• Carboplatin in 2D vs 3D Cancer Models: Translational Impact

  2026-06-09

  Discover how Carboplatin, a platinum-based DNA synthesis inhibitor, reveals distinct responses in 2D versus 3D preclinical oncology models. This article uniquely explores proteomic insights to optimize cancer research protocols.

• Oligo (dT) 25 Beads: Technical Guide for Eukaryotic mRNA Iso

  2026-06-08

  Oligo (dT) 25 Beads offer a streamlined solution for the isolation of polyadenylated eukaryotic mRNA from total RNA, cell, or tissue lysates. This product is optimal for workflows requiring high-purity mRNA for downstream applications like cDNA synthesis and RT-PCR, but is not suitable for non-eukaryotic or non-polyadenylated RNA targets.

• TMRE Mitochondrial Membrane Potential Assay Kit: Applied Wor

  2026-06-08

  The TMRE mitochondrial membrane potential assay kit empowers researchers to achieve high-throughput, quantitative mitochondrial function analysis and cell apoptosis detection. Explore optimized workflows, troubleshooting strategies, and advanced applications that set this assay apart for precision research in mitochondrial physiology and disease.

• Nigericin Sodium Salt: Technical Guidance for Ion Transport

  2026-06-07

  Nigericin sodium salt is a selective potassium ionophore for controlled manipulation of ion gradients and cytoplasmic pH in cell-based and biochemical assays. It is specifically suited for workflows involving ion transport across biological membranes, platelet aggregation modulation, and lead (Pb2+) ion transport studies. This reagent is not intended for diagnostic or medical applications; strict protocol adherence is needed for reliable results.

16519 records 1/1102 page Next 12345 下5页 Last page